King Luther Capital Management Corp bought a new stake in Becton, Dickinson and Company (NYSE:BDX) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,807 shares of the medical instruments supplier’s stock, valued at approximately $331,000.

Other hedge funds have also modified their holdings of the company. Guardian Life Insurance Co. of America raised its stake in shares of Becton, Dickinson and by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 819 shares of the medical instruments supplier’s stock valued at $150,000 after buying an additional 6 shares in the last quarter. Wellington Shields & Co. LLC raised its stake in shares of Becton, Dickinson and by 0.3% in the first quarter. Wellington Shields & Co. LLC now owns 2,534 shares of the medical instruments supplier’s stock valued at $465,000 after buying an additional 8 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after buying an additional 9 shares in the last quarter. Northstar Group Inc. raised its stake in shares of Becton, Dickinson and by 0.3% in the first quarter. Northstar Group Inc. now owns 2,985 shares of the medical instruments supplier’s stock valued at $550,000 after buying an additional 10 shares in the last quarter. Finally, Capital Investment Advisors LLC raised its stake in shares of Becton, Dickinson and by 0.7% in the first quarter. Capital Investment Advisors LLC now owns 2,412 shares of the medical instruments supplier’s stock valued at $442,000 after buying an additional 17 shares in the last quarter. 75.61% of the stock is owned by institutional investors and hedge funds.

Becton, Dickinson and Company (NYSE BDX) traded down 0.93% during trading on Friday, reaching $197.05. The company’s stock had a trading volume of 2,176,468 shares. Becton, Dickinson and Company has a 52 week low of $161.29 and a 52 week high of $206.63. The company has a market cap of $42.03 billion, a P/E ratio of 32.73 and a beta of 1.05. The company’s 50 day moving average price is $197.67 and its 200 day moving average price is $186.53.

Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 26.07%. The company had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. During the same period in the prior year, the business posted $2.35 EPS. The company’s quarterly revenue was down 5.1% on a year-over-year basis. On average, equities analysts anticipate that Becton, Dickinson and Company will post $9.45 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.73 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.48%. Becton, Dickinson and’s dividend payout ratio is 83.43%.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/08/06/king-luther-capital-management-corp-buys-shares-of-1807-becton-dickinson-and-company-nysebdx.html.

Several analysts recently issued reports on BDX shares. Zacks Investment Research lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Thursday, May 4th. Evercore ISI upgraded Becton, Dickinson and from an “in-line” rating to an “outperform” rating and increased their price objective for the stock from $186.00 to $200.00 in a report on Monday, April 24th. Raymond James Financial, Inc. upgraded Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and cut their price objective for the stock from $210.00 to $180.00 in a report on Friday, June 30th. Royal Bank Of Canada reiterated a “hold” rating and set a $177.00 price objective on shares of Becton, Dickinson and in a report on Thursday, April 13th. Finally, Bank of America Corporation reiterated a “buy” rating and set a $225.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Becton, Dickinson and presently has a consensus rating of “Buy” and a consensus target price of $194.69.

In other news, VP Jeffrey S. Sherman sold 28,765 shares of the stock in a transaction dated Thursday, May 25th. The shares were sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the completion of the transaction, the vice president now directly owns 70,821 shares in the company, valued at approximately $13,171,289.58. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.40% of the company’s stock.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.